Literature DB >> 2223891

Exercise intervention attenuates emotional distress and natural killer cell decrements following notification of positive serologic status for HIV-1.

A R LaPerriere1, M H Antoni, N Schneiderman, G Ironson, N Klimas, P Caralis, M A Fletcher.   

Abstract

The impact of aerobic exercise training as a buffer of the affective distress and immune decrements which accompany the notification of HIV-1 antibody status in an AIDS risk group was studied. Fifty asymptomatic gay males with a pretraining fitness level of average or below (determined by predicted VO2 max) were randomly assigned to either an aerobic exercise training program or a no-contact control condition. After five weeks of training, at a point 72 hours before serostatus notification, psychometric, fitness and immunologic data were collected on all subjects. Psychometric and immunologic measures were again collected one-week postnotification. Seropositive controls showed significant increases in anxiety and depression, as well as decrements in natural killer cell number following notification whereas, seropositive exercisers showed no similar changes and in fact, resembled both seronegative groups. These findings suggest that concurrent changes in some affective and immunologic measures in response to an acute stressor might be attenuated by an experimentally manipulated aerobic exercise training intervention.

Entities:  

Mesh:

Year:  1990        PMID: 2223891     DOI: 10.1007/bf01011107

Source DB:  PubMed          Journal:  Biofeedback Self Regul        ISSN: 0363-3586


  22 in total

1.  Maximal oxygen uptake in athletes.

Authors:  B Saltin; P O Astrand
Journal:  J Appl Physiol       Date:  1967-09       Impact factor: 3.531

2.  Physician use of the HIV antibody test. The need for consent, counseling, confidentiality, and caution.

Authors:  R Sherer
Journal:  JAMA       Date:  1988-01-08       Impact factor: 56.272

3.  A comparison of training responses to interval versus continuous aerobic dance.

Authors:  A Perry; P Mosher; A La Perriere; M Roalstad; P Ostrovsky
Journal:  J Sports Med Phys Fitness       Date:  1988-09       Impact factor: 1.637

4.  Decreased natural cell-mediated cytotoxicity per effector cell in acquired immunodeficiency syndrome.

Authors:  G C Baron; N G Klimas; M A Fischl; M A Fletcher
Journal:  Diagn Immunol       Date:  1985

5.  Fitness standards for male college students.

Authors:  E L Fox; C E Billings; R L Bartels; R Bason; D Mathews
Journal:  Int Z Angew Physiol       Date:  1973-03-02

Review 6.  Mechanism of cytotoxicity by natural killer (NK) cells.

Authors:  R B Herberman; C W Reynolds; J R Ortaldo
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

7.  Compliance and exercise in primary and secondary prevention of coronary heart disease: a review.

Authors:  N B Oldridge
Journal:  Prev Med       Date:  1982-01       Impact factor: 4.018

8.  Use of whole blood methods in assessment of immune parameters in immunodeficiency states.

Authors:  M A Fletcher; G C Baron; M R Ashman; M A Fischl; N G Klimas
Journal:  Diagn Clin Immunol       Date:  1987

9.  Activation of human NKCC by moderate exercise: increased frequency of NK cells with enhanced capability of effector--target lytic interactions.

Authors:  S Targan; L Britvan; F Dorey
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

10.  Life events, depressive symptoms, and immune function.

Authors:  M Irwin; M Daniels; E T Bloom; T L Smith; H Weiner
Journal:  Am J Psychiatry       Date:  1987-04       Impact factor: 18.112

View more
  29 in total

1.  Impact of Aerobic and Resistance Exercise on the Health of HIV-Infected Persons.

Authors:  Gregory A Hand; G William Lyerly; Jason R Jaggers; Wesley D Dudgeon
Journal:  Am J Lifestyle Med       Date:  2009-11-01

2.  A bereavement support group intervention is longitudinally associated with salutary effects on the CD4 cell count and number of physician visits.

Authors:  K Goodkin; D J Feaster; D Asthana; N T Blaney; M Kumar; T Baldewicz; R S Tuttle; K J Maher; M K Baum; P Shapshak; M A Fletcher
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

3.  Social cognitive and physical health determinants of exercise adherence for HIV-1 seropositive, early symptomatic men and women.

Authors:  R M Pavone; K F Burnett; A LaPerriere; F M Perna
Journal:  Int J Behav Med       Date:  1998

4.  Aerobic and resistance exercise training effects on body composition, muscular strength, and cardiovascular fitness in an HIV-1 population.

Authors:  C L Lox; E McAuley; R S Tucker
Journal:  Int J Behav Med       Date:  1996

5.  Distress, denial, and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus.

Authors:  G Ironson; A Friedman; N Klimas; M Antoni; M A Fletcher; A Laperriere; J Simoneau; N Schneiderman
Journal:  Int J Behav Med       Date:  1994

Review 6.  Evaluating the Effectiveness of Physical Exercise Interventions in Persons Living With HIV: Overview of Systematic Reviews.

Authors:  Emiko Kamitani; Theresa Ann Sipe; Darrel H Higa; Mary M Mullins; Jesus Soares
Journal:  AIDS Educ Prev       Date:  2017-08

Review 7.  Exercise and human immunodeficiency virus (HIV-1) infection.

Authors:  D Lawless; C G Jackson; J E Greenleaf
Journal:  Sports Med       Date:  1995-04       Impact factor: 11.136

Review 8.  Human immunodeficiency virus infection, exercise and athletics.

Authors:  L H Calabrese; A LaPerriere
Journal:  Sports Med       Date:  1993-01       Impact factor: 11.136

Review 9.  The benefits of exercise training for quality of life in HIV/AIDS in the post-HAART era.

Authors:  Joseph T Ciccolo; Esbelle M Jowers; John B Bartholomew
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

10.  Physical activity and health outcomes among HIV-infected men who have sex with men: a longitudinal mediational analysis.

Authors:  Aaron J Blashill; Kenneth H Mayer; Heidi Crane; Jessica F Magidson; Chris Grasso; W Christopher Mathews; Michael S Saag; Steven A Safren
Journal:  Ann Behav Med       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.